Steve Perrin from Eledon Pharmaceuticals shares how a novel immunosuppressive drug may improve outcomes for transplant recipients. Summary Steve Perrin of Eledon Pharmaceuticals discusses a promising new immunosuppressive drug designed to enhance transplant outcomes. Unlike Read More
Tags :targeted
Education, Research & Positions
Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable
Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study Summary This study investigated the effectiveness of combining transarterial embolization (TAE), hepatic arterial infusion chemotherapy (HAIC), targeted therapy, Read More
A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the parasite responsible for the deadliest form of human malaria, that could make novel, highly targeted anti-malarial therapies Read More